| Ditemukan 1191 dokumen dengan kata kunci 7255 |
Simpan CSV  |
|
Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trial
|
| No. Panggil: Rheumatology; Volume 53, No.9, September 2014: p.1654-1663 | | Location: Perpustakaan FT |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Comparison of three enthesitis indices in a multicentre, randomized, placebo-controlled trial of golimumab in ankylosing spondylitis (GO-RAISE)
|
| No. Panggil: Rheumatology; Volume 52, No.2, February 2013: p.321-325 | | Location: Perpustakaan FT |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis—a randomized, placebo-controlled pilot trial
|
| No. Panggil: Rheumatology; Volume 53, No.6, June 2014: p.1065-1074 | | Location: Perpustakaan FT |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Tumour necrosis factor inhibitor therapy and infection risk in axial spondyloarthritis: results from a longitudinal observational cohort
|
| No. Panggil: Rheumatology; Volume 54, No.1, January 2015: p.152-156 | | Location: Perpustakaan FT |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Drug survival of anti-tumour necrosis factor a therapy in spondyloarthropathies: results from the Spanish emAR II Study
|
| No. Panggil: Rheumatology; Volume 54, No.8, August 2015: p.1459-1463 | | Location: Perpustakaan FT |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up
|
| No. Panggil: Rheumatology; Volume 52, No.7, July 2013: p.1313-1322 | | Location: Perpustakaan FT |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial
|
| No. Panggil: Rheumatology; Volume 52, No.7, July 2013: p.1285-1292 | | Location: Perpustakaan FT |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register
|
| No. Panggil: Rheumatology; Volume 52, No.4, April 2013: p.712-717 | | Location: Perpustakaan FT |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
I.V. APD421 (amisulpride) prevents postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled, multicentre trial
|
| No. Panggil: British Journals Anaesthesia; Volume 111, No.6, December 2013, p.938-945 | | Location: Perpustakaan FT |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Safety of resuming tumour necrosis factor inhibitors in patients who developed tuberculosis as a complication of previous TNF inhibitors
|
| No. Panggil: Rheumatology; Volume 53, No.8, August 2014: p.1477-1481 | | Location: Perpustakaan FT |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
Hasil Pencarian
